Important statement on using GLI vs. GOLD spirometry criteria for the diagnosis of #COPD
publications.ersnet.org/content/erj/...
Posts by Samir Nusair MD ๐ฎ๐ฑ
Excellent review on modern therapeutic options available for #scleroderma
rmdopen.bmj.com/content/11/3...
There are no Piranhas in Africa
Mixing science with music
'39
youtu.be/K9jvseJDN2k?...
The importance of bedside teaching of #Medicine
#MedicinePractice #MedicalEducation
www.nejm.org/doi/full/10....
What Drives #LungCancer in Nonsmokers?
This is rapidly growing clinical problem
www.medscape.com/viewarticle/...
Sjogren disease therapy making nice progress since I reviewed pilocarpine for xerostomia in SS 25 years ago. Read "research in context" box.
www.thelancet.com/journals/lan...
Very interesting ๐
small vessel vasculitis-necrosis?
Antifibrotic therapy does not alter the natural history of #pulmonaryhypertension in #pulmonaryfibrosis and other #progressivePF #fibroticILD
bmcpulmmed.biomedcentral.com/articles/10....
Dyspnea worsening is a strong predictor of ILD progression in #Scleroserma and unlinked to changes in pulmonary function test
www.sciencedirect.com/science/arti...
FDG accumulation (or lack of uptake) within interstitial lesions does not predict acute exacerbation risk in lung cancer
#pulmonaryfibrosis
link.springer.com/article/10.1...
Inhaled Recombinant human GM-CSF given 48w shows clinically significant ,around 10% rise in DLCO, with some yet not statistically significant improvement in QOL or Exercise capacity in #alveolarproteinosis #raredisease
Our dog is inspired in her sleep, dreaming and runnig while I listen to an old lecture from the late Prof. Brian Whipp
#ExercisePhysiology #ExerciseTesting
#ERSCongress 2007
Another therapeutic option for #pulmonaryfibrosis is coming up: Admilparant, a Lysophosphatidic Acid Receptor 1 Antagonist for IPF and PPF
journal.chestnet.org/article/S001...
All is good. Would reclassification help us to adjust optimal treatment and improve outcomes and clinical decisions? I sure hope so.
publications.ersnet.org/content/erj/...
Intriguing findings suggest that #Calcium Supplementation and even more together with Genetic Susceptibility may increase the incidence of Idiopathic #PulmonaryFibrosis.
A prospective cohort study.
www.sciencedirect.com/science/arti...
Seems my point is well taken. Injury, enforces abstaining from exercise or modifications that compromise benefit on mitochondria.
I presume there is a J-curve in which heavy repeated load may have eventually a toll on the integrity and function of joints and supporting soft tissue.
How come with increased wisdom and knowledge in this age there is more idiocy?
A new approach to achieve weight loss, by increasing thermogenesis and promoting metabolism
www.nature.com/articles/s42...
the effect on 'later life' is valid if you maintain a life long training pattern
On the Cover of @annalsats.bsky.social a picture of the pediatric department from which the senior author of this paper comes. The building was savagely attacked by an Iranian missile On June the 19th.
Dupilumab and #lymphoma risk among patients with #asthma: a population-based cohort study #BiologicsAsthma
Increased incidence of T and NK cell lymphoma and CTCL.
Clinical implications, yet to be determined.
publications.ersnet.org/content/erj/...
On the devastating damage the researchers at Weizmann institute sustained from an Iranian missle
www.ynet.co.il/health/artic...
An @atscommunity.bsky.social podcast on environmental factors contributing to interstitial lung disease #pulmonaryfibrosis #fibroticILD
castbox.fm/app/castbox/...
Rentosertib, A generative AI-discovered TNIK inhibitor for idiopathic #pulmonaryfibrosis: a randomized phase 2a trial
Interesting if consistently confirmed effective, seems to have a relatively small rate of GI side effects.
www.nature.com/articles/s41...
So banal and so understanable.
Remarkable: a treatment for progressive pulm. fibrosis #fibroticILD. #Nerandomilast a molecule with #antifibrotic and anti-inflammatory effect, slows down FVC deterioration. Additionally, a weak signal of benefit on secondary end points, seen beyond week 52 of therapy.
www.nejm.org/doi/full/10....
Nerandomilast slows FVC deterioration in IPF patients without/with background #antifibrotic therapy.
- No additional protection from IPF exacerbation
- Pirfenidone decreases plasma levels of Nerandomilast by 50% as opposed to nintedanib.
#pulmonaryfibrosis #ATS2025
www.nejm.org/doi/full/10....